Becker's Healthcare March 22, 2023
Erica Carbajal

Drug shortages, which increased nearly 30 percent from 2021 to 2022, pose health and national security risks, according to a new report from the Senate Committee on Homeland Security and Governmental Affairs.

“Shortages of critical medications continue to rise — including drugs used in hospital emergency rooms and to treat cancer, prescription medications, and even some common over-the-counter treatments like children’s cold and flu medicine,” the report said, according to a copy obtained by NBC News.

The number of active drug shortages in the U.S. hit a peak of 295 at the end of 2022. This is driven by economic factors, inadequate supply chain visibility, and the nation’s reliance on foreign sources for drugs and raw materials, the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Trends
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs
Big Pharma's ROI for drug R&D saw 'welcome' rebound in 2023: report
STAT+: Why a British hospital, and not a drugmaker, is trying to get a rare disease therapy approved
STAT+: Profiting from ‘legal’ insider trading isn’t always easy
Regeneron expands in gene editing with Mammoth deal

Share This Article